Recombinant human, active site-blocked factor VIIa reduces infarct size and the no-reflow phenomenon in a rabbit model of myocardial ischemia and reperfusion

被引:0
|
作者
Golino, P
Ragni, M
Cirillo, P
Ravera, A
Buono, G
Piro, O
Botticella, F
Ezban, M
Chiariello, M
机构
[1] Univ Naples Federico II, Div Cardiol, Naples, Italy
[2] Novo Nordisk AS, Dept Vessel Wall Biol, DK-2820 Gentofte, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1481
引用
收藏
页码:468 / 468
页数:1
相关论文
共 50 条
  • [1] Recombinant human, active site-blocked factor VII reduces infarct size and the NO-reflow phenomenon in a rabbit model of myocardial ischemia and reperfusion
    Golino, P
    Ragni, M
    Cirillo, P
    DAndrea, D
    Ravera, A
    Buono, C
    Corcione, N
    Vigorito, F
    Ezban, M
    Chiariello, M
    CIRCULATION, 1997, 96 (08) : 4166 - 4166
  • [2] Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits
    Golino, P
    Ragni, M
    Cirillo, P
    Scognamiglio, A
    Ravera, A
    Buono, C
    Guarino, A
    Piro, O
    Lambiase, C
    Botticella, F
    Ezban, M
    Condorelli, M
    Chiariello, M
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (05): : H1507 - H1516
  • [3] Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis
    Golino, P
    Ragni, M
    Cirillo, P
    D'Andrea, D
    Scognamiglio, A
    Ravera, A
    Buono, C
    Ezban, M
    Corcione, N
    Vigorito, F
    Condorelli, M
    Chiariello, M
    CIRCULATION RESEARCH, 1998, 82 (01) : 39 - 46
  • [4] Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion
    Hale, Sharon L.
    Kloner, Robert A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (01) : 50 - 54
  • [5] Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion
    Sharon L. Hale
    Robert A. Kloner
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 50 - 54
  • [6] Empagliflozin reduces both infarct size and no-reflow in a rat experimental myocardial ischemia/reperfusion model
    Dai, Wangde
    Carreno, Juan
    Pahlevan, Niema
    Alavi, Rashid
    Chavez, Jesus
    Kloner, Robert
    CIRCULATION, 2024, 150
  • [7] Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model
    Dai, Wangde
    Hale, Sharon
    Kloner, Robert A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 400 - 404
  • [8] RAMIPRILAT REDUCES MYOCARDIAL INFARCT SIZE IN A RABBIT MODEL OF ISCHEMIA/REPERFUSION
    HARTMAN, J
    WALL, T
    HULLINGER, T
    WILLIAMS, L
    SHEBUSKI, R
    FASEB JOURNAL, 1992, 6 (04): : A943 - A943
  • [9] Delayed Therapeutic Hypothermia Protects Against the Myocardial No-reflow Phenomenon Independent of Infarct Size in a Rat Ischemia/reperfusion Model
    Dai, Wangde
    Kloner, Robert A.
    CIRCULATION, 2016, 134
  • [10] Characterization of Myocardial Infarct and No-reflow Size in Zucker Diabetic Fatty Rat Myocardial Ischemia/Reperfusion Model
    Dai, Wangde
    Carreno, Juan
    Shi, Jianru
    Hale, Sharon
    Kloner, Robert A.
    CIRCULATION, 2017, 136